- Home
- EHTH vs HBIO Comparison
EHTH vs HBIO Comparison
Compare EHTH & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- HBIO
- Stock Information
- Founded
- EHTH 1997
- HBIO 1901
- Country
- EHTH United States
- HBIO United States
- Employees
- EHTH N/A
- HBIO N/A
- Industry
- EHTH Specialty Insurers
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- EHTH Finance
- HBIO Industrials
- Exchange
- EHTH Nasdaq
- HBIO Nasdaq
- Market Cap
- EHTH 130.5M
- HBIO 117.7M
- IPO Year
- EHTH 2006
- HBIO 2000
- Fundamental
- Price
- EHTH $4.55
- HBIO $2.37
- Analyst Decision
- EHTH Hold
- HBIO
- Analyst Count
- EHTH 3
- HBIO 0
- Target Price
- EHTH $6.67
- HBIO N/A
- AVG Volume (30 Days)
- EHTH 107.0K
- HBIO 123.3K
- Earning Date
- EHTH 11-06-2024
- HBIO 11-05-2024
- Dividend Yield
- EHTH N/A
- HBIO N/A
- EPS Growth
- EHTH N/A
- HBIO N/A
- EPS
- EHTH N/A
- HBIO N/A
- Revenue
- EHTH $471,200,000.00
- HBIO $101,125,000.00
- Revenue This Year
- EHTH $8.91
- HBIO N/A
- Revenue Next Year
- EHTH $5.83
- HBIO $2.68
- P/E Ratio
- EHTH N/A
- HBIO N/A
- Revenue Growth
- EHTH 20.76
- HBIO N/A
- 52 Week Low
- EHTH $3.58
- HBIO $2.35
- 52 Week High
- EHTH $9.45
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- EHTH 63.17
- HBIO 31.13
- Support Level
- EHTH $4.04
- HBIO $2.38
- Resistance Level
- EHTH $4.51
- HBIO $2.53
- Average True Range (ATR)
- EHTH 0.17
- HBIO 0.12
- MACD
- EHTH 0.06
- HBIO -0.03
- Stochastic Oscillator
- EHTH 98.65
- HBIO 4.65
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.